These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
291 related articles for article (PubMed ID: 21994752)
1. Controversies in targeted therapy of adult T cell leukemia/lymphoma: ON target or OFF target effects? Nasr R; El Hajj H; Kfoury Y; de Thé H; Hermine O; Bazarbachi A Viruses; 2011 Jun; 3(6):750-69. PubMed ID: 21994752 [TBL] [Abstract][Full Text] [Related]
2. Suppression of Type I Interferon Production by Human T-Cell Leukemia Virus Type 1 Oncoprotein Tax through Inhibition of IRF3 Phosphorylation. Yuen CK; Chan CP; Fung SY; Wang PH; Wong WM; Tang HV; Yuen KS; Chan CP; Jin DY; Kok KH J Virol; 2016 Apr; 90(8):3902-3912. PubMed ID: 26819312 [TBL] [Abstract][Full Text] [Related]
3. ATL response to arsenic/interferon therapy is triggered by SUMO/PML/RNF4-dependent Tax degradation. Dassouki Z; Sahin U; El Hajj H; Jollivet F; Kfoury Y; Lallemand-Breitenbach V; Hermine O; de Thé H; Bazarbachi A Blood; 2015 Jan; 125(3):474-82. PubMed ID: 25395419 [TBL] [Abstract][Full Text] [Related]
4. Therapy-induced selective loss of leukemia-initiating activity in murine adult T cell leukemia. El Hajj H; El-Sabban M; Hasegawa H; Zaatari G; Ablain J; Saab ST; Janin A; Mahfouz R; Nasr R; Kfoury Y; Nicot C; Hermine O; Hall W; de Thé H; Bazarbachi A J Exp Med; 2010 Dec; 207(13):2785-92. PubMed ID: 21135137 [TBL] [Abstract][Full Text] [Related]
5. Adult T-cell leukemia-lymphoma as a viral disease: Subtypes based on viral aspects. Nosaka K; Matsuoka M Cancer Sci; 2021 May; 112(5):1688-1694. PubMed ID: 33630351 [TBL] [Abstract][Full Text] [Related]
6. Phase II trial of arsenic trioxide and alpha interferon in patients with relapsed/refractory adult T-cell leukemia/lymphoma. Hermine O; Dombret H; Poupon J; Arnulf B; Lefrère F; Rousselot P; Damaj G; Delarue R; Fermand JP; Brouet JC; Degos L; Varet B; de Thé H; Bazarbachi A Hematol J; 2004; 5(2):130-4. PubMed ID: 15048063 [TBL] [Abstract][Full Text] [Related]
7. Treatment of adult T-cell leukaemia/lymphoma: current strategy and future perspectives. Bazarbachi A; Hermine O Virus Res; 2001 Oct; 78(1-2):79-92. PubMed ID: 11520582 [TBL] [Abstract][Full Text] [Related]
8. Arsenic-interferon-alpha-triggered apoptosis in HTLV-I transformed cells is associated with tax down-regulation and reversal of NF-kappa B activation. El-Sabban ME; Nasr R; Dbaibo G; Hermine O; Abboushi N; Quignon F; Ameisen JC; Bex F; de Thé H; Bazarbachi A Blood; 2000 Oct; 96(8):2849-55. PubMed ID: 11023521 [TBL] [Abstract][Full Text] [Related]
9. Phase 2 study of the efficacy and safety of the combination of arsenic trioxide, interferon alpha, and zidovudine in newly diagnosed chronic adult T-cell leukemia/lymphoma (ATL). Kchour G; Tarhini M; Kooshyar MM; El Hajj H; Wattel E; Mahmoudi M; Hatoum H; Rahimi H; Maleki M; Rafatpanah H; Rezaee SA; Yazdi MT; Shirdel A; de Thé H; Hermine O; Farid R; Bazarbachi A Blood; 2009 Jun; 113(26):6528-32. PubMed ID: 19411628 [TBL] [Abstract][Full Text] [Related]
10. Interferon-α (IFN-α) suppresses HTLV-1 gene expression and cell cycling, while IFN-α combined with zidovudine induces p53 signaling and apoptosis in HTLV-1-infected cells. Kinpara S; Kijiyama M; Takamori A; Hasegawa A; Sasada A; Masuda T; Tanaka Y; Utsunomiya A; Kannagi M Retrovirology; 2013 May; 10():52. PubMed ID: 23688327 [TBL] [Abstract][Full Text] [Related]
11. Arsenic/interferon specifically reverses 2 distinct gene networks critical for the survival of HTLV-1-infected leukemic cells. Nasr R; Rosenwald A; El-Sabban ME; Arnulf B; Zalloua P; Lepelletier Y; Bex F; Hermine O; Staudt L; de Thé H; Bazarbachi A Blood; 2003 Jun; 101(11):4576-82. PubMed ID: 12560223 [TBL] [Abstract][Full Text] [Related]
12. Hachiman M; Yoshimitsu M; Ezinne C; Kuroki A; Kozako T; Arima N Oncol Lett; 2018 Jul; 16(1):1305-1311. PubMed ID: 30061950 [TBL] [Abstract][Full Text] [Related]
14. Zidovudine and interferon-alpha treatment induces a high response rate and reduces HTLV-1 proviral load and VEGF plasma levels in patients with adult T-cell leukemia from North East Iran. Kchour G; Makhoul NJ; Mahmoudi M; Kooshyar MM; Shirdel A; Rastin M; Rafatpanah H; Tarhini M; Zalloua PA; Hermine O; Farid R; Bazarbachi A Leuk Lymphoma; 2007 Feb; 48(2):330-6. PubMed ID: 17325893 [TBL] [Abstract][Full Text] [Related]
15. Overview of Targeted Therapies for Adult T-Cell Leukemia/Lymphoma. Nasr R; Marçais A; Hermine O; Bazarbachi A Methods Mol Biol; 2017; 1582():197-216. PubMed ID: 28357672 [TBL] [Abstract][Full Text] [Related]
16. Niclosamide, an anti-helminthic molecule, downregulates the retroviral oncoprotein Tax and pro-survival Bcl-2 proteins in HTLV-1-transformed T lymphocytes. Xiang D; Yuan Y; Chen L; Liu X; Belani C; Cheng H Biochem Biophys Res Commun; 2015 Aug; 464(1):221-228. PubMed ID: 26116531 [TBL] [Abstract][Full Text] [Related]
18. Arsenic trioxide and interferon-alpha synergize to induce cell cycle arrest and apoptosis in human T-cell lymphotropic virus type I-transformed cells. Bazarbachi A; El-Sabban ME; Nasr R; Quignon F; Awaraji C; Kersual J; Dianoux L; Zermati Y; Haidar JH; Hermine O; de Thé H Blood; 1999 Jan; 93(1):278-83. PubMed ID: 9864171 [TBL] [Abstract][Full Text] [Related]
19. Role of the HTLV-1 viral factors in the induction of apoptosis. Karimi M; Mohammadi H; Hemmatzadeh M; Mohammadi A; Rafatpanah H; Baradaran B Biomed Pharmacother; 2017 Jan; 85():334-347. PubMed ID: 27887847 [TBL] [Abstract][Full Text] [Related]
20. HTLV-1 Infection and Adult T-Cell Leukemia/Lymphoma-A Tale of Two Proteins: Tax and HBZ. Giam CZ; Semmes OJ Viruses; 2016 Jun; 8(6):. PubMed ID: 27322308 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]